Banking service chronicle this article was published in the magazine incovacc it is worlds first intranasal vaccine which received approval for covid booster doses from drugs controller general of india (dcgi). Banking service chronicle magazine it is a recombinant replication deficient adenovirus virus vectored vaccine. adenovirus is a nuclear-replicating dna virus with a linear double-stranded genome. covid suraksha program of department of biotechnology helped to partially finance product development and clinical trials Banking service chronicle magazine subscription.
No comments:
Post a Comment